ACE Report Cover
Better left ventricular function and MAP with xenon vs. propofol in non-cardiac surgery
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
GENERAL ORTHOPAEDICS
Better left ventricular function and MAP with xenon vs. propofol in non-cardiac surgery .
Verified
This report has been verified by one or more authors of the original publication.

Xenon or propofol anaesthesia for patients at cardiovascular risk in non-cardiac surgery

Br J Anaesth. 2008 May;100(5):605-11. doi: 10.1093/bja/aen050. Epub 2008 Mar 15.

40 patients with, or at risk for, coronary artery disease and undergoing non-cardiac surgery were randomized to receive either a xenon-opioid anaesthetic or propofol-opioid anaesthetic. The purpose of this study was to compare these two interventions with respect to the preservation of left ventricular function, as well as intraoperative mean arterial pressure. Results indicated that xenon yielded significantly better results with respect to left ventricular performance, mean arterial pressure and heart rate when compared to propofol anaesthesia. The incidence of postoperative nausea and vomiting, however, was significantly increased with xenon.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Better left ventricular function and MAP with xenon vs. propofol in non-cardiac surgery. ACE Report. 2014;3(10):69. Available from: https://myorthoevidence.com/AceReport/Show/better-left-ventricular-function-and-map-with-xenon-vs-propofol-in-non-cardiac-surgery

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report